K Steffen,Mareike Rockel,Burkhard von Jagow
K Steffen
[Principles of progression assessment-How can the progression of a disease be measured?] [0.03%]
[进展性评定原则——如何衡量疾病的进展?]
Christian van Oterendorp,Peter P Eckstein,Claudia Lommatzsch
Christian van Oterendorp
The basic principles for the assessment of the progression of a chronic disease are universal. When they and their rules are understood, they can be used for different diseases and investigations. This article describes the different trajec...
Elias Flockerzi,Berthold Seitz,Stefan Johann Lang
Elias Flockerzi
Keratectasias including keratoconus are pathological curvature anomalies of the human cornea, which can progress and lead to permanent visual impairment. Corneal crosslinking can be used to stabilize the disease. Criteria for performing cro...
[Predictors of the appropriateness of first presentation in an university ophthalmology outpatient clinic: an analysis of sociodemographic factors] [0.03%]
[大学眼科门诊首次就诊适当性的预测因素：一种社会人口学因素分析]
L Malagutti,D Böhringer,T Reinhard
L Malagutti
Background: The increasing shortage of specialists in ophthalmology and the rising burden on university eye clinics raise questions about the appropriateness of the utilization of university resources. This study investig...
Christian van Oterendorp,Claudia Lommatzsch
Christian van Oterendorp
Progression monitoring is essential for glaucoma management. In addition to perimetry, optical coherence tomography (OCT) has become established as a valuable supplement. It provides morphological information on the retinal nerve fiber laye...
[Corneal events with mirvetuximab soravtansine : A review of ocular surface events associated with the tubulin-acting antibody-drug conjugate, mirvetuximab soravtansine] [0.03%]
Mirvetuximab Soravtansine相关角膜事件：一种以微管为作用位点的抗体药物偶联物所致眼表不良反应综述
Ramin Khoramnia,Gerald Schmidinger
Ramin Khoramnia
Antibody-drug conjugates (ADC) are a class of targeted anticancer therapy that consist of a monoclonal antibody (linker) and a cytotoxic substance. Ocular adverse events (AEs) are common among ADCs with tubulin-targeted active agents, such ...
[Trabecular, suprachoroidal and subconjunctival innovative glaucoma surgery : S1 guidelines of the German Society of Ophthalmology (DOG) and the German Professional Association of Ophthalmologists (BVA)] [0.03%]
【小梁、超乳突和结膜下创新性青光眼手术：德国眼科学会(DGOG)和德国眼科医师协会(BVA)的S1指南】
Deutsche Ophthalmologische Gesellschaft (DOG);Berufsverband der Augenärzte Deutschlands e. V. (BVA)
Deutsche Ophthalmologische Gesellschaft (DOG);Berufsverband der Augenärzte Deutschlands e. V. (BVA)
[Photobiomodulation for AMD : Statement of the German Society of Ophthalmology, the German Retina Society and the German Professional Association of Ophthalmologists. Status 4 July 2025] [0.03%]
[光生物调制治疗年龄相关性黄斑变性的德国眼科学会、德国视网膜学会和德国眼科医师协会声明。2025年7月4日更新]
Deutsche Ophthalmologische Gesellschaft (DOG);Retinologische Gesellschaft e. V. (RG);Berufsverband der Augenärzte Deutschlands e. V. (BVA)
Deutsche Ophthalmologische Gesellschaft (DOG);Retinologische Gesellschaft e. V. (RG);Berufsverband der Augenärzte Deutschlands e. V. (BVA)
[Ocular graft-versus-host disease : S1 guidelines of the German Society of Ophthalmology (DOG) and the German Professional Association of Ophthalmologists (BVA)] [0.03%]
[德国眼科学会(DOG)和德国眼科医师协会(BVA)的S1指南：ocular移植物抗宿主病]
Deutsche Ophthalmologische Gesellschaft (DOG);Berufsverband der Augenärzte Deutschlands e. V. (BVA)
Deutsche Ophthalmologische Gesellschaft (DOG);Berufsverband der Augenärzte Deutschlands e. V. (BVA)
[Herpes simplex virus keratitis : S1 guidelines of the German Society of Ophthalmology (DOG) and the German Professional Association of Ophthalmologists (BVA)] [0.03%]
[单纯疱疹病毒性角膜炎德国眼科学会(DOG)和德国眼科医师协会(BVA)S1指南]
Deutsche Ophthalmologische Gesellschaft (DOG);Berufsverband der Augenärzte Deutschlands e. V. (BVA)
Deutsche Ophthalmologische Gesellschaft (DOG);Berufsverband der Augenärzte Deutschlands e. V. (BVA)